Salt-induced cardiac hypertrophy is independent of blood pressure and endothelin in obese, heart failure-prone SHHF rats.
The interaction of salt sensitivity and obesity in development of cardiac hypertrophy is incompletely understood. The SHHF/Mcc-fa(cp) (SHHF) rat model was used to examine the effect of high salt on cardiac hypertrophy and expression of endothelin (ET) and nitric oxide synthase (NOS) isoforms. Homozygous lean (+/+) and obese (fa(cp)/fa(cp)) SHHF were fed a low-salt diet (0.3% NaCl) for seven days followed by a high-salt diet (8.0% NaCl) for seven days. To assess the role of ET in mediating cardiac hypertrophy and gene expression with high salt, additional groups were treated with an ET(A)/ET(B) receptor antagonist (bosentan) while on high salt. Obese SHHF showed an increase in systolic blood pressure and cardiac hypertrophy in response to the high-salt diet. High salt resulted in decreased expression of preproET as well as all three NOS isoforms in the Obese, while cytokine induced NOS (iNOS) and neuronal NOS (nNOS) increased in Leans. Though the salt-sensitive component of the hypertension observed in the Obese was prevented by bosentan, cardiac hypertrophy still occurred and expression of all NOS isoforms remained lower in Obese compared to Lean. Endothelial NOS (eNOS) expression increased in the Lean with bosentan. These studies suggest that cardiac hypertrophy is independent of the level of hypertension and may be mediated by altered production of NOS isoforms in salt-sensitive, obese SHHF.
Radin
M Judith
MJ
Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio 43210, USA. radin.1.@osu.edu
Holycross
Bethany J
BJ
Hoepf
Toni M
TM
McCune
Sylvia A
SA
D000818:Animals; D001483:Base Sequence; D001794:Blood Pressure; D000077300:Bosentan; D006332:Cardiomegaly / Q000209:etiology* / Q000235:genetics / Q000503:physiopathology; D017931:DNA Primers / Q000235:genetics; D065128:Endothelin Receptor Antagonists; D016232:Endothelins / Q000235:genetics / Q000378:metabolism*; D015870:Gene Expression; D006333:Heart Failure / Q000209:etiology / Q000235:genetics / Q000503:physiopathology*; D020738:Leptin / Q000097:blood; D008297:Male; D019001:Nitric Oxide Synthase / Q000235:genetics / Q000378:metabolism; D009765:Obesity / Q000150:complications / Q000235:genetics / Q000503:physiopathology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017673:Sodium Chloride, Dietary / Q000009:adverse effects; D013449:Sulfonamides / Q000494:pharmacology
D017931:DNA Primers; D065128:Endothelin Receptor Antagonists; D016232:Endothelins; D020738:Leptin; D012333:RNA, Messenger; D017673:Sodium Chloride, Dietary; D013449:Sulfonamides; D019001:Nitric Oxide Synthase; D000077300:Bosentan